Free Trial
→ Nvidia’s CEO: “This Will Be a Multitrillion-Dollar Industry.' (From Brownstone Research) (Ad) Free LEXX Stock Alerts

Lexaria Bioscience (LEXX) SEC Filings & 10K Form

Lexaria Bioscience logo
$1.45 +0.02 (+1.40%)
Closing price 02/21/2025 04:00 PM Eastern
Extended Trading
$1.46 +0.01 (+0.34%)
As of 02/21/2025 05:30 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.
Compare

Recent Lexaria Bioscience SEC Filings

Export to Excel
DateFilerForm TypeView
01/30/2025
11:15 PM		Lexaria Bioscience Corp. (Filer)
Lexaria Bioscience (Filer)
Lexaria Bioscience Corp. (Filer)
Form EFFECT
01/16/2025
10:39 AM		Bhullar Baljinder (Reporting)
Lexaria Bioscience Corp. (Issuer)
Lexaria Bioscience (Issuer)
Lexaria Bioscience Corp. (Issuer)
Form 3
Initial statement of beneficial ownership of securities  
01/15/2025
11:02 AM		Lexaria Bioscience Corp. (Filer)
Lexaria Bioscience (Filer)
Lexaria Bioscience Corp. (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
01/10/2025
1:19 PM		Lexaria Bioscience Corp. (Filer)
Lexaria Bioscience (Filer)
Lexaria Bioscience Corp. (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
01/10/2025
10:52 AM		BUNKA CHRISTOPHER (Reporting)
Lexaria Bioscience Corp. (Issuer)
Lexaria Bioscience (Issuer)
Lexaria Bioscience Corp. (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
01/06/2025
1:57 PM		Lexaria Bioscience Corp. (Filer)
Lexaria Bioscience (Filer)
Lexaria Bioscience Corp. (Filer)
Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans  
01/03/2025
11:48 AM		Lexaria Bioscience Corp. (Filer)
Lexaria Bioscience (Filer)
Lexaria Bioscience Corp. (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
12/18/2024
12:08 PM		Lexaria Bioscience Corp. (Filer)
Lexaria Bioscience (Filer)
Lexaria Bioscience Corp. (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
12/17/2024
11:15 PM		Lexaria Bioscience Corp. (Filer)
Lexaria Bioscience (Filer)
Lexaria Bioscience Corp. (Filer)
Form EFFECT
12/05/2024
11:15 PM		Lexaria Bioscience Corp. (Filer)
Lexaria Bioscience (Filer)
Lexaria Bioscience Corp. (Filer)
Form EFFECT
12/05/2024
3:56 PM		Lexaria Bioscience Corp. (Filer)
Lexaria Bioscience (Filer)
Lexaria Bioscience Corp. (Filer)
Form 424B3
12/03/2024
1:03 PM		CHRISTOPHER RICHARD (Reporting)
Lexaria Bioscience Corp. (Issuer)
Lexaria Bioscience (Issuer)
Lexaria Bioscience Corp. (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
11/27/2024
1:39 PM		Lexaria Bioscience Corp. (Filer)
Lexaria Bioscience (Filer)
Lexaria Bioscience Corp. (Filer)
Form DEF 14A
11/26/2024
12:01 PM		Lexaria Bioscience Corp. (Filer)
Lexaria Bioscience (Filer)
Lexaria Bioscience Corp. (Filer)
Form 10-K
Annual report pursuant to Section 13 or 15(d)  
11/12/2024
10:38 AM		Lexaria Bioscience Corp. (Filer)
Lexaria Bioscience (Filer)
Lexaria Bioscience Corp. (Filer)
Form PRE 14A
10/18/2024
3:42 PM		Lexaria Bioscience Corp. (Filer)
Lexaria Bioscience (Filer)
Lexaria Bioscience Corp. (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
10/16/2024
4:18 PM		Lexaria Bioscience Corp. (Filer)
Lexaria Bioscience (Filer)
Lexaria Bioscience Corp. (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
10/16/2024
2:30 PM		Lexaria Bioscience Corp. (Filer)
Lexaria Bioscience (Filer)
Lexaria Bioscience Corp. (Filer)
Form D
Notice of Exempt Offering of Securities 
10/16/2024
5:54 AM		Lexaria Bioscience Corp. (Filer)
Lexaria Bioscience (Filer)
Lexaria Bioscience Corp. (Filer)
Form 424B5
10/02/2024
2:45 PM		Lexaria Bioscience Corp. (Issuer)
Lexaria Bioscience (Issuer)
Lexaria Bioscience Corp. (Issuer)
Shankman Michael Elliot (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
10/02/2024
11:21 AM		Lexaria Bioscience Corp. (Filer)
Lexaria Bioscience (Filer)
Lexaria Bioscience Corp. (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
09/23/2024
12:28 PM		Boos Wayne W (Filed by)
Lexaria Bioscience Corp. (Subject)
Lexaria Bioscience (Subject)
Lexaria Bioscience Corp. (Subject)
Form SC 13D/A
09/05/2024
12:09 PM		CHRISTOPHER RICHARD (Reporting)
Lexaria Bioscience Corp. (Issuer)
Lexaria Bioscience (Issuer)
Lexaria Bioscience Corp. (Issuer)
Form 3
Initial statement of beneficial ownership of securities  
09/05/2024
9:11 AM		Lexaria Bioscience Corp. (Filer)
Lexaria Bioscience (Filer)
Lexaria Bioscience Corp. (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/21/2024
6:55 PM		Lexaria Bioscience Corp. (Filer)
Lexaria Bioscience (Filer)
Lexaria Bioscience Corp. (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/13/2024
9:55 AM		Lexaria Bioscience Corp. (Issuer)
Lexaria Bioscience (Issuer)
Lexaria Bioscience Corp. (Issuer)
TURKEL CATHERINE C. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
08/01/2024
11:25 AM		Carle Vanessa (Reporting)
Lexaria Bioscience Corp. (Issuer)
Lexaria Bioscience (Issuer)
Lexaria Bioscience Corp. (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
07/30/2024
10:39 AM		Lexaria Bioscience Corp. (Issuer)
Lexaria Bioscience (Issuer)
Lexaria Bioscience Corp. (Issuer)
REESE ALBERT L JR (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
07/30/2024
10:25 AM		Baxter Nicholas W (Reporting)
Lexaria Bioscience Corp. (Issuer)
Lexaria Bioscience (Issuer)
Lexaria Bioscience Corp. (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
07/30/2024
10:32 AM		Lexaria Bioscience Corp. (Issuer)
Lexaria Bioscience (Issuer)
Lexaria Bioscience Corp. (Issuer)
TURKEL CATHERINE C. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
07/30/2024
10:12 AM		Lexaria Bioscience Corp. (Issuer)
Lexaria Bioscience (Issuer)
Lexaria Bioscience Corp. (Issuer)
McKechnie William Edward (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
07/12/2024
12:26 PM		Lexaria Bioscience Corp. (Filer)
Lexaria Bioscience (Filer)
Lexaria Bioscience Corp. (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
06/11/2024
11:15 PM		Lexaria Bioscience Corp. (Filer)
Lexaria Bioscience (Filer)
Lexaria Bioscience Corp. (Filer)
Form EFFECT
06/03/2024
12:05 PM		Lexaria Bioscience Corp. (Filer)
Lexaria Bioscience (Filer)
Lexaria Bioscience Corp. (Filer)
Form S-1
Registration statement under Securities Act of 1933  
05/15/2024
4:37 PM		Carle Vanessa (Reporting)
Lexaria Bioscience Corp. (Issuer)
Lexaria Bioscience (Issuer)
Lexaria Bioscience Corp. (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
05/10/2024
4:16 PM		Lexaria Bioscience Corp. (Issuer)
Lexaria Bioscience (Issuer)
Lexaria Bioscience Corp. (Issuer)
TURKEL CATHERINE C. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/10/2024
4:24 PM		Carle Vanessa (Reporting)
Lexaria Bioscience Corp. (Issuer)
Lexaria Bioscience (Issuer)
Lexaria Bioscience Corp. (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
05/10/2024
4:03 PM		Lexaria Bioscience Corp. (Issuer)
Lexaria Bioscience (Issuer)
Lexaria Bioscience Corp. (Issuer)
McKechnie William Edward (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/10/2024
4:11 PM		Baxter Nicholas W (Reporting)
Lexaria Bioscience Corp. (Issuer)
Lexaria Bioscience (Issuer)
Lexaria Bioscience Corp. (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
05/10/2024
3:34 PM		DOCHERTY JOHN MARTIN (Reporting)
Lexaria Bioscience Corp. (Issuer)
Lexaria Bioscience (Issuer)
Lexaria Bioscience Corp. (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
05/10/2024
3:44 PM		BUNKA CHRISTOPHER (Reporting)
Lexaria Bioscience Corp. (Issuer)
Lexaria Bioscience (Issuer)
Lexaria Bioscience Corp. (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
Nvidia’s CEO: “This Will Be a Multitrillion-Dollar Industry." (Ad)

If you missed out on the big boom in Nvidia… Listen up, because according to Nvidia's own CEO… Elon Musk’s new technology could help launch an entirely new multitrillion-dollar industry.

You MUST act before March 17th.
05/02/2024
1:18 PM		Lexaria Bioscience Corp. (Filer)
Lexaria Bioscience (Filer)
Lexaria Bioscience Corp. (Filer)
Form D
Notice of Exempt Offering of Securities 
04/30/2024
2:13 PM		Lexaria Bioscience Corp. (Filer)
Lexaria Bioscience (Filer)
Lexaria Bioscience Corp. (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
04/25/2024
3:57 PM		Boos Wayne W (Filed by)
Lexaria Bioscience Corp. (Subject)
Lexaria Bioscience (Subject)
Lexaria Bioscience Corp. (Subject)
Form SC 13D/A
04/24/2024
10:38 AM		Lexaria Bioscience Corp. (Filer)
Lexaria Bioscience (Filer)
Lexaria Bioscience Corp. (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
04/09/2024
3:12 PM		Lexaria Bioscience Corp. (Filer)
Lexaria Bioscience (Filer)
Lexaria Bioscience Corp. (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
03/21/2024
3:37 PM		Lexaria Bioscience Corp. (Filer)
Lexaria Bioscience (Filer)
Lexaria Bioscience Corp. (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
03/20/2024
11:15 PM		Lexaria Bioscience Corp. (Filer)
Lexaria Bioscience (Filer)
Lexaria Bioscience Corp. (Filer)
Form EFFECT
03/20/2024
4:00 PM		Lexaria Bioscience Corp. (Filer)
Lexaria Bioscience (Filer)
Lexaria Bioscience Corp. (Filer)
Form 424B3
03/15/2024
3:22 PM		Cabatuan Nelson (Reporting)
Lexaria Bioscience Corp. (Issuer)
Lexaria Bioscience (Issuer)
Lexaria Bioscience Corp. (Issuer)
Form 3
Initial statement of beneficial ownership of securities  
03/15/2024
3:09 PM		Lexaria Bioscience Corp. (Filer)
Lexaria Bioscience (Filer)
Lexaria Bioscience Corp. (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
03/12/2024
4:09 PM		Lexaria Bioscience Corp. (Filer)
Lexaria Bioscience (Filer)
Lexaria Bioscience Corp. (Filer)
Form S-1
Registration statement under Securities Act of 1933  
03/06/2024
5:00 AM		Lexaria Bioscience Corp. (Filer)
Lexaria Bioscience (Filer)
Lexaria Bioscience Corp. (Filer)
Form DEF 14A
03/01/2024
1:28 PM		Lexaria Bioscience Corp. (Filer)
Lexaria Bioscience (Filer)
Lexaria Bioscience Corp. (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
(Data available from 1/1/2016 forward)


Related Companies and Tools

Related Companies
SEC Filings Tools

This page (NASDAQ:LEXX) was last updated on 2/22/2025 by MarketBeat.com Staff
From Our Partners
Nvidia’s Next Big Move Comes on Feb. 26
Nvidia isn't the only company that benefits greatly from these earnings calls. That's because a handful of ...
Weiss Ratings | Sponsored
A strange twist 500 miles from Washington
Energy is life. And this year, it could also make national heroes out of President Trump and VP Vance. ...
Porter & Company | Sponsored
Major AI announcement for 2025
BIG NEWS: “Market Wizard” Larry Benedict Releases a Whole New Way to Trade AI Stocks
Brownstone Research | Sponsored